Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,506.48
(
-1.51%
)
US TECH 100
23,484.80
(
-0.99%
)
Dow Jones
45,577.47
(
-0.96%
)
Brent Oil
106.93
(
0.00%
)
Bitcoin
70,710.99
(
0.28%
)
News Focus
News Focus
Post# of 257266
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

go seek

Send PM Follow Ignore
Followers 23
Posts 5144
Boards Moderated 0
Alias Born 06/24/2006

go seek

Re: None

Monday, 09/25/2006 11:00:47 PM

Monday, September 25, 2006 11:00:47 PM

Post# of 257266
IDIX PR announcement... Twice

Note: 2nd time adds "including an update of the company's clinical program"

What is expected?
Ribaviron interaction study (NM283 2b leg) start?

CAMBRIDGE, Mass., Sept 19, 2006 /PRNewswire-FirstCall via COMTEX/ -- Idenix Pharmaceuticals, Inc. (IDIX) announced today that Idenix management will present a corporate overview at the upcoming UBS 2006 Global Life Sciences Conference on Wednesday, September 27, 2006 at 11:30 a.m. ET at the Grand Hyatt New York.

CAMBRIDGE, Mass., Sept 25, 2006 /PRNewswire-FirstCall via COMTEX/ -- Idenix Pharmaceuticals, Inc. (IDIX) announced today that Idenix management will present a corporate overview, including an update of the company's clinical program, at the upcoming UBS 2006 Global Life Sciences Conference on Wednesday, September 27, 2006 at 11:30 a.m. ET at the Grand Hyatt New York.

The creation of a thousand forests is in one acorn.

Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today